Short takes: BioScrip, Rotech

 - 
Wednesday, January 10, 2018

Denver-based BioScrip can now dispense and administer HEMLIBRA, a treatment for routine prophylaxis approved by the U.S. Food and Drug Administration. The drug helps to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A with factor VIII inhibitors. “BioScrip continues to expand our therapy offering to better care for the patients that we support,” said Robert Roose, senior vice president and chief procurement officer. “Receiving the approval to dispense and administer HEMLIBRA underscores the fact that BioScrip is a destination of choice for our manufacturers.” BioScrip will provide HEMLIBRA in the patient’s home or in an infusion setting, depending on the patient’s care plan and conditions….Made4Net, a global provider of supply chain software solutions, has released a case study showing how Rotech Healthcare optimized its inventory levels and fulfillment process using WarehouseExpert WMS. Where Made4net made the biggest difference: inventory accuracy and visibility. Rotech’s previous manual reporting inserted delays and could lead to inaccurate counts. “It was all manual, so we didn’t have a way to see our current inventory in real time,” said Rotech’s inventory supervisor. “The best we could do was a day behind, and much of the time it wasn’t completely accurate, but we started cycle counting with the new system five months ago and we are now at 99.8% accuracy.”